MiMedx Group, Inc (MDXG): Price and Financial Metrics
MDXG Price/Volume Stats
| Current price | $6.24 | 52-week high | $9.27 |
| Prev. close | $6.43 | 52-week low | $3.49 |
| Day low | $5.65 | Volume | 1,588,500 |
| Day high | $6.30 | Avg. volume | 770,774 |
| 50-day MA | $7.51 | Dividend yield | N/A |
| 200-day MA | $7.54 | Market Cap | 917.02M |
MDXG Stock Price Chart Interactive Chart >
MiMedx Group, Inc (MDXG) Company Bio
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue.
Latest MDXG News From Around the Web
Below are the latest news stories about MIMEDX GROUP INC that investors may wish to consider to help them evaluate MDXG as an investment opportunity.
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common StockMARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation. As a result of this conversion, approximatel |
Is MiMedx Group, Inc. (NASDAQ:MDXG) Trading At A 50% Discount?Key Insights Using the 2 Stage Free Cash Flow to Equity, MiMedx Group fair value estimate is US$17.71 MiMedx Group's... |
MIMEDX to Participate in Upcoming Investor ConferencesMARIETTA, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum Capital Group 14th Annual Alpha Select Conference Thursday, November 16, 2023Sheraton New York Times Square Hotel811 7th Avenue, W 53rd St New York, NY Mizuho Medical Device & Healthcare Services Summit 2023Wednesday, December 6, 2023Sofitel New York45 W 44th StNew |
MIMEDX to Highlight Published Data at SAWC FallCompany Will Sponsor Lunch Symposium on November 3, 2023MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place November 2-5 in Las Vegas, NV. In addition, the Company will participate in the conference’s exhibition at booth number 511. In the session, Drs. Mouawad, Tettelbach, and Wahab will review r |
Loss-Making MiMedx Group, Inc. (NASDAQ:MDXG) Set To BreakevenMiMedx Group, Inc. ( NASDAQ:MDXG ) is possibly approaching a major achievement in its business, so we would like to... |
MDXG Price Returns
| 1-mo | -18.00% |
| 3-mo | -22.39% |
| 6-mo | 1.46% |
| 1-year | 70.96% |
| 3-year | 19.08% |
| 5-year | 417.84% |
| YTD | -28.85% |
| 2023 | 215.47% |
| 2022 | -53.97% |
| 2021 | 33.04% |
| 2020 | 19.79% |
| 2019 | 323.46% |
Loading social stream, please wait...